Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-10-31
2006-10-31
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
C424S439000
Reexamination Certificate
active
07129230
ABSTRACT:
A pet food containing vitamin D analogs for use in treatment of cancer in pets, such as dogs and cats, is described. Also described is a method for treating pets, such as dogs and cats, for cancer by feeding the pet a pet food containing at least one vitamin D analog.
REFERENCES:
patent: 4022891 (1977-05-01), Takeshita et al.
patent: 4341774 (1982-07-01), Aoki et al.
patent: 4364941 (1982-12-01), Kiyoki et al.
patent: 4442093 (1984-04-01), Maeda et al.
patent: 4948789 (1990-08-01), Slatopolsky
patent: 5043170 (1991-08-01), Borenstein et al.
patent: 5063221 (1991-11-01), Nishii et al.
patent: 5087619 (1992-02-01), Baggiolini et al.
patent: 5145846 (1992-09-01), Baggiolini et al.
patent: 5183815 (1993-02-01), Saari et al.
patent: 5250523 (1993-10-01), DeLuca et al.
patent: 5597815 (1997-01-01), Deluca et al.
patent: 5602116 (1997-02-01), Knutson et al.
patent: 5707980 (1998-01-01), Knutson et al.
patent: 5861386 (1999-01-01), Knutson et al.
patent: 5869473 (1999-02-01), Knutson et al.
patent: 5972917 (1999-10-01), Bishop et al.
Yu et al., Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia, abstract, PMID: 7756673, Feb. 1995.
Katzung, Basic and Clinical Pharmocology, 1995, pp. 661-663, 838, 841, 830-832, 537-538.
Hardman et al., Goodman and Gilman's The pharmacological Basis of Therapeutics, ninth edition1996, p. 539.
Bouillon et al., Endocrine Reviews, 995; 16(2):200-257.
Abdaimi et al., Cancer Research, 1999; 59:3325-3328.
Yu, J.; Papavasiliou, V; Rhim, J; Goltzman, D; Kremer, R: “Vitamin D Analogs: New Therapeutic Agents For The Treatment Of Squamous Cancer And Its Associated Hypercalcemia,”Anticancer DrugsFeb. 1995;6(1):101-8, abstract only.
Werkmeister, Jr; Merryman, Ji; McCauley, L; Horton, JE; Capen, CC; Rosol, TJ; “Parathyroid Hormone-related Protein Production By Normal Human Keratinocytes In Vitro,”Exp Cell ResSep. 1993;208(1):68-74, abstract only.
Merryman, JI; Capen, CC; McCauley, LK; Werkmeister, Jr; Suter, MM; Rosol, TJ: “Regulation Of Parathyroid Hormone-related Protein Production By A Squamous Carcinoma Cell Line In Vitro,”Lab InvestSep. 1993;69(3):347-54, abstract only.
Wang, X; Chen, X.; Akhter, J; Morris, DL: “TheIn VitroEffect Of Vitamin D3 Analogue EB-1089 On A Human prostate Cancer Cell Line (PC-3),”British Journal Of Urology(1997), 80, 260-262.
Colston, KW; James, SY; Ofori-Kuragu, EA; Binderup, L; Grant, AG: “Vitamin D Receptors And Anti-proliferative Effects Of Vitamin D Derivatives In Human Pancreatic Carcinoma Cells In Vivo And In Vitro,”British Journal of Cancer(1997)76(8), 1017-1020.
Berg, Jens P.; Liane, Kjellaug, M.; Bjørhovde, Siri B.; Bjøro, Trine; Torjesen, Peter A.; Haug, Egil: Vitamin D Receptor Binding And Biological Effects Of Cholecalciferol Analogues In Rat Thyroid Cells,:J. Steroid Biochem.Molec.Biol. vol. 50.
Skowronski, Roman J.; Peehl, Donna M.; Feldman, David: “Actions Of Vitamin D3Analogs On Human Prostate Cancer Cell Lines: Comparison With 1,25-Dihydroxyvitamin D3,”Encocrinology1995 by The Endocrine Society.
Koli, Katri; Keski-Oja, Jorma: “1,25-Dihydroxyvitamin D3Enhances The Expression Of Transforming Growth Factor B1 And Its Latent Form Binding Protein In cultured Breast Carcinoma Cells,”Cancer Research55, 1540-1546, Apr. 1, 1995.
Moore, Theodore B.; Koeffler, H. Phillip; Yamashiro, Joyce M.; Wada, Randal K.: “Vitamin D3Analogs Inhibit Growth And Induce differentiation In LA-N-5 Human Neuroblastoma Cells,”Clin.Exp. Metastasis, 1996, 14, 239-245.
Zhou, Jian-Yuan; Norman, Anthony W.; Chen, Dan-Lin; Sun, Guo-Wen; Uskokovic, Milan: “1-25-Dihydroxy-16-ene-23-yne-vitamin D3Prolongs Survival Time Of Leukemic Mice,”Proc. Natl. Acad. Sci. USA, vol. 87, pp. 3939-3932 May 1990 Medical Sciences.
Zhou, Jian-Yuan; Norman, A.W.; Lubvert, M.; Collins, E.D.; Uskokovic, M.R.; Koeffler, H.P.: “Novel Vitamin D Analogs That Modulate Leukemic Cell Growth And Differentiation With Little Effect On Either Intestinal Calcium Absorption Or Bone Calcium Mobilization,”Blood, vol. 74, No. 1Jul. 1989: pp. 82-93.
Norman, Anthony W.; Zhou, J.Y.; Henry, Helen L.; Uskokovic, Milan R.; Koeffler, H. Phillip: “Structure-Function Studies On Analogues Of 1α, 25-Dihydroxyvitamin D3: Differential Effects on Leukemic Cell Growth, Differentiation, and Intestinal Calcium Absorption,”Cancer Research50,6857-6864, Nov. 1, 1990.
Norman, AW; Sergeev, IN; Bishop, JE; Okamura, WH: “Selective Biological Response By Target Organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3:and Two Analogues,”Cancer Res(United States), Sep. 1, 1993, 53 (17) p. 3935-42, abstract only.
Shams, G; Romstedt, KJ; Gerhardt, MA; Harrold, MW; Miller, DD: Feller, DR: “Pharmacological Evaluation of the Beta-adrenoceptor Agonist and Thromboxane Receptor Blocking Properties of 1-benzyl Substituted Trimetoquinol Analogues,”J Pharmacol(Netherlands), Aug. 2, 1990, 184 (1) p. 21-31, abstract only.
Pressova, M; Smrt, J: “Lipid Derivatives of (2′-5′) Oligo A,”Nucleic Acids Symp Ser(England), 1987, (18) p. 101-4, abstract only.
Tse, FL; Christiano, Jr; Talbot, KC: “Relative Absorption of Trytophan Ethyl Ester Amide Derivatives With Various Fatty Acid Chains In The Dog,”J Pharm Pharmacol(England), Sep. 1984, 36(9) p. 633-6, abstract only.
Bikolics, K; Bieglmayer, C; Spona, J; Serprodi, J; Teplan, I: “Inhibition of LH-release By Synthetic Analogues of LH-RH in Rat Pituitary Cell Culture,”Peptides(United States), Spring 1981, 2(1) p. 65-73, abstract only.
Gudkov, ND; Stolovitskii, Ium; Evstigneev, VB: “Impulse Photoconductivity of Solutions of Chlorophyll and its Analogs,”Biofizika(USSR), Mar.-Apr. 1975, 20(2) p. 214-8, abstact only.
Lan, SJ; Dean, AV; Walker, BD; Schreiber, EC: “Metabolism of a Benzothiazine Compound by the Intact Rat, Isolated Perfused Rat Liver, and Rat-liver Microsomes,”Xenobiotica(England), Mar. 1976,6(3) p. 171-83, abstract only.
Poirer, MA; Black, DB; Lovering, EG: “Formation of Alkyl Carbamates From Glyburide: Potential for Overestimation in the BP Glibenclamide (Glyburide) Foreign Substances Test,”Can. J. Pharm. Sci.; vol. 15 ISS, Jan. 1980, p. 8-9, abstract only.
Bowman, JC; Beroza, M; Harding, JA: “Determination of Phorate and Five of Its Metabolites in Corn,”J. Agr. Food Chem.; 17(1), 138-42, 1969, abstract only.
Uchiyama, Minoru; Murakami, Toshiki: “Effects of AVT and Vascular Antagonists on Kidney function and Smooth Muscle Contraction in the River Lamprey, Lampetra Japonica,”Comparative Biochemistry and Physiology A Comparative Physiology, 107 (3):p. 493-499 1994, abstract only.
Manhi, FM; Abdel-Fattah, AM: “Reactions with 6-substituted-2-thiouracil-5-carbonitriles. Synthesis of Tetrazolo (1,5-c) and Ditetrazolo (1, 5-a: 1, 5-c) Pyrimidines,”Egyptian Journal of Pharmaceutical Sciences, 33 (5-6):p. 825-838, 1992 (1993), abstract only.
Compton, DR; Johnson, MR; Melvin, LS; Martin, BR: “Pharmacological Profile of a Series of Bicyclic Cannabinoid Analogs Classification as Cannabimimetic Agents,”J Pharmacol Exp Ther 260(1). 1992. 201-209, abstract only.
Ahmad, MS; Husain, SR; Husain M.; Choudhry, ZH: “On The synthesis of Some More Steroidal Tetrazoles,”Indian J Chem Sect B Org Chem Incl Med Chem 16(7). 1978 559-562, abstract only.
Chu, CK; Reichman, U; Watanabe, KA; Fox, JJ: “Nucleosides Part 109 2 Deoxy-PSI ISO Cytidine 2 Deoxy-PSI Uridine and 2 Deoxy-1-Methyl-PSI Uridine Isosteres of Deoxy Cytidine Deoxy Uridine and Thymidine,”J Heterocyclic Chemistry, 14 (6). 1977 1119-1121, abstract only.
Chinn, MK; Myburgh, KH; Pham, T; Franksskiba, K; Cooke, R.: “The Effect of Polyethylene Glycol on the Mechanics and ATPase Activity of Active Muscle Fibers,”Biophysical Journal, 2000, V78, N2 (Feb.), p. 927-939, abstract only.
Kumar, V; Coulsell, E;
Hui San-Ming
Nestec S.A.
LandOfFree
Method and product for treating cancer in pets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and product for treating cancer in pets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and product for treating cancer in pets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3676512